Geert-Jan Mulder, MD

Geert-Jan is Managing Partner at Forbion and has a leading role in the firm’s investment team and portfolio. He is an experienced life sciences investor who is led Forbion’s successful investments and served on the Boards of several Forbion portfolio companies, sometimes also in an executive capacity. In addition to his portfolio management activities, he works closely with management teams of various Forbion portfolio companies on clinical development strategies and regulatory matters, such as IND/NDA filings, Special Protocol Approval (SPA), and US/EU Orphan designations for several products – reflected by being a co-author of many Forbion and Forbion-portfolio-related scientific publications.

Scroll to Top